We are a leading Mexican pharmaceutical laboratory in the development, manufacture, and commercialization of generic, biotechnological, and other quality and efficacy health supplies.
We operate two pharmaceutical plants with the latest technology, under certified processes and procedures, rigorous controls and quality standards required by national and international health authorities.
We have a solid portfolio made up of more than 200 product presentations that cover the demand of the export market, private and of the main public health institutions in Mexico.
Our commitment to the well-being of the population has prompted us to invest in the research and development of high-specialty, biotechnological, genomic medicine, and currently medicinal cannabis treatments.
With more than 20 years of experience, at Landsteiner Scientific® we will continue innovating the pharmaceutical industry in the country and beyond its borders.
State-of-the-Art Operations (200k+ sq. ft, 6.3 billion-piece GMP facility).
Uniquely positioned to be first-mover and market leader in burgeoning Mexican legal cannabis market.
Launching new Business Division dedicated exclusively to medical applications of fungi.
Forming Joint Venture with leading direct sales company in Mexico, CV Directo, to expand consumer facing distribution capabilities.
A health and wellness division built and designed to extend Mexico market share and capture the U.S. Hispanic market opportunity.
Our laboratory belongs to the Landsteiner Scientific Group, a consortium made up of four companies specialized in the pharmaceutical sector, as well as in the research and development of health and wellness products based in Mexico and its affiliated company in Spain.
The executive team that leads our company has more than 25 years of experience, both in its expertise area as in the Mexican pharmaceutical industry.
Miguel Granados, CEO.